Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14613399 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy
Condition: Atopic Dermatitis
Interventions: Drug: Altabax (R);   Drug: Vehicle and Locoid lipocream (R)

Indicates status has not been verified in more than two years